NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 87 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 205.18 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,000 | +33.3% | 61,496 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $6,000 | -57.1% | 61,496 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $14,000 | -75.4% | 61,496 | +105.0% | 0.00% | -78.6% |
| Q4 2014 | $57,000 | +338.5% | 30,000 | +200.0% | 0.01% | +366.7% |
| Q3 2014 | $13,000 | -13.3% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $15,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |